COLLABORATIVE PROJECTS

TRANSBIO SUDOE aims at promoting interdisciplinary and interregional research in the field of health & life sciences.
TRANSBIO SUDOE can provide mobility support (transport & accommodation) for scientists interested in setting up collaborative research projects.

Below the procedure to launch a collaborative project :
  1. Create a TRANSBIO account => registration
  2. When approved, enter the intranet via the Enter TRANSBIO SUDOE bottom bar
  3. Select in partner access => Post collaborative project
For all questions or further help, contact your regional local WP2 mini-cluster responsible..

Develop clinical trials for a new drug for dialysis patients

Partner A Member : Isles Baleares
Name of principal investigator : PERELLO
Firstname : Joan
Email : joan.perello@sanifit.com
Position : Staff
Affiliation Name : Sanifit Laboartories
Road : Valldemossa
Postbox : 07121
Town : Palma de Mallorca
Country : Spain
Partner B Member : Barcelona
Name of principal investigator : CAMPISTOL
Firstname : Josep maria
Email : JMCAMPIS@clinic.ub.es
Position : Staff
Affiliation Name : Institut Clinic Nefrologia Urologia (ICNU)
Road : villarroel 170
Postbox :
Town : Barcelona
Country :
Request for financial support 2 scientists for 8 days (Partner A to Partner B)
Request for technical support :
- Need of TTO's support to ease collaboration agreements :
No
- Need for identification of funding opportunities (regional, national, European) : No

Added value of the cooperation : Share know-how / expertise

Summary of the proposal : Develop clinical trials for a new drug for dialysis patients SNF472 till phase II.

Development of in-vivo and in-vitro assays. The first indication pursued for SNF472 is the treatment of calciphylaxis, a rare disease that affects between 1 and 4% of dialysis patients, with an average life expectancy of 1 year since his diagnosis. Calciphylaxis has its origin in the massive cardiovascular calcification of small peripheral blood vessels and there are currently no approved alternative treatments. Sanifit received orphan drug designation for SNF472 by the EMA and by the FDA.

Ricardo RODRIGUEZ, Galicia
Anais GONZALEZ, Barcelona

CARE-U: take control of your health whichever you are
Denis DUPUY, Bordeaux
Julian CERON MADRIGAL, Barcelona
Sonia DA ROCHA, Bordeaux
Functional genomic analysis of the LSM-like protein family in C. elegans
Jorge PINTO PAIVA, Lisboa
Jacqueline GRIMA-PETTENATI, Toulouse
Olga SERRA FIGUERAS, Barcelona
SW European consortium for forest genomics: Transcriptional regulation and post-transcriptional regulation of secondary cell wall in forest trees\\\"
Joaquin DOPAZO, Valencia
Ligia SARAIVA, Lisboa

RNA-seq studies of Gram-negative pathogens
Ana ESTEVEZ, Lisboa
Lourdes LOURDES VEGA, Barcelona
Pineiro MANUEL PINEIRO, Galicia
Development of New Artificial Blood Substitutes using Fluorinated Ionic Liquids
Ana VARELA COELHO, Lisboa
Salvador VENTURA, Barcelona
Francesc CANALS, Barcelona
DiggingLabel‐free high resolution MS
Jose louis ROSELLO, Isles Baleares
Franciso CODONER, Valencia

development of Field Programmable Gate Arrays
Raquel SA LEAO, Lisboa
Carmen MUNOZ-ALMAGRO, Barcelona

Improved detection of Streptococcus pneumoniae from carriage samples using non-culturable methods
Pedro SALEMA-FEVEREIRO, Lisboa
Pere PUIGDOMENECH-ROSELL, Barcelona

Using DNA editing strategies to increase crop tolerance towards emergent environmental stresses
Maria manuela CHAVES, Lisboa
Hipolito MEDRANO, Isles Baleares

Variability of water use efficiency in grapevines
Joan PERELLO, Isles Baleares
Josep maria CAMPISTOL, Barcelona

Develop clinical trials for a new drug for dialysis patients
View proposal
Carla ANTONIO, Lisboa
Laetitia FOUILLEN, Bordeaux

Understanding drought response and recovery in Medicago truncatula using state-of-the-art metabolomics/lipidomics technologies